Not too late to short MRK and SGP
Submitted by pharmaking (bestcashcow.com)
While Merck and Schering Plough have already fallen hard, they should both continue to fall for the forseeable future
Investing, Stocks, Income, Value, Economy, Dividends, Buffett, Passive, Retirements, Dividend, Recession, Stock, Market, Retirement, Apple, Personal finance, Banks, Stock market, Google, Real estate, Housing, Inflation, Oil, Credit, Interest rates.
Related Tags: Buffett, Investing, Income, Retirements, Dividends, Value, Passive, Stocks, Mrk, Lly, Sgp, Azn, Pep, Abt, Ko, Jnj, Intc, Vytorin, Dell, Lipids, Jpm, Mhs, Dri, Mcd, Ranexa.
Earlier we looked at measuring risk of dividend stocks with the RQ (Risk/Quality) ratings. This was a good start, but it didn't quite go far enough. Since then I have continued to measure,...
I always enjoy this time of year. The Christmas music, decorations, family gatherings, holiday plays and stock picks. Stock picks? Yes, 'tis the season for stock predictions! Here are some excerpts...
Dividend investors have a lot to be thankful for. The 60 companies making up the Dividend Aristocrats have outperformed the S&P 500 index year-to-date by almost 12 percentage points. SmartMoney...
The election is over and no matter how you feel about Obama, he will be the next U.S. president. A sharp increase in new debt could push up interest rates and continue the downward pressure on the...
Investors have long enjoyed a love-hate relationship with pharmaceutical stocks. This sector is unique in that their products are effectively scheduled for obsolescence via expiring patents. As...
When investors purchase their initial position in a stock, it is usually after their most rigorous research. Once a stock is in their portfolio, some investors relax on the research for subsequent...
While Merck and Schering Plough have already fallen hard, they should both continue to fall for the forseeable future
Here is how I anticipate the big trials out of the AHA panning out and how you can trade based on these projected results
Merck just released phase II data on a drug called a CETP. The stock has been moving up- at least partially on this news. This drug is very unlikely to ever reach the market. I don't understand...
The results of a large meta-analysis of statin trials were released tonight on CNBC - to be published in JACC - although I don't see it the ACC website and haven't received the journal yet. This...
| Page 1 of 1 |
BestCashCow provides information on the best CD (certificates of deposit) rates, the best money market rates, the best savings rates, and more - as well as financial information that can help you make better decisions with your money.
|
Type
|
Top APY/Rate
|
Institution
|
|
4.00%
|
Dollar Savings Direct
|
|
|
2.21%
|
Vanguard
|
|
|
2.50%
|
EverBank / Umbrella Bank
|
|
|
3.15%
|
GMAC Bank
|
|
|
3.75%
|
GMAC Bank
|
|
|
3.50%
|
GMAC Bank
|
|
|
3.70%
|
MetLife Bank
|
|
|
3.80%
|
MetLife Bank
|
|
4.10% |
Acacia Federal Savings Bank |
|
|
4.50%
|
Acacia Federal Savings Bank
|
|
|
5.64%
|
US Treasury
|
|
|
3.37%
|
Northrop Grumman CU
|
|
|
3.87%
|
Western FCU
|
|
|
3.80%
|
Melrose CU
|
|
|
4.25%
|
Alliant CU
|
|
|
0.05%
|
Various brokerages
|
|
|
0.51%
|
Various brokerages
|
|
|
1.10%
|
Various brokerages
|
|
|
1.65%
|
Various brokerages
|
|
|
2.67%
|
Various brokerages
|
See more product and rate information
Where do you think Interest rates are going?
Analysis of CD, Savings, and Money Market Rate Trends.